Literature DB >> 26739459

Human T-cell leukemia virus type 1 (HTLV-1) Tax1 oncoprotein but not HTLV-2 Tax2 induces the expression of OX40 ligand by interacting with p52/p100 and RelB.

Yosuke Motai1,2, Masahiko Takahashi1, Takayuki Takachi3, Masaya Higuchi1, Toshifumi Hara1, Mariko Mizuguchi4, Yutaka Aoyagi2, Shuji Terai2, Yuetsu Tanaka5, Masahiro Fujii6.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is a causative retrovirus of adult T-cell leukemia and HTLV-1-associated myelopathy. Unlike HTLV-1, the same group of retrovirus HTLV-2 has not been found to be associated with these diseases. HTLV-1 and HTLV-2 encode transforming proteins Tax1 and Tax2, and a few distinct activities of Tax1 from those of Tax2 have been proposed to contribute to the HTLV-1-specific pathogenesis of disease. One significant difference of Tax1 from Tax2 is the activation of transcription factor NF-κB2/p100/p52. We found that Tax1 but not Tax2 induces the expression of OX40 ligand (OX40L) in a human T-cell line. To induce the OX40L expression, Tax1 but not Tax2 was observed to interact with NF-κB2/p100/p52 and RelB and the distinct interaction activity was mediated by the Tax1 amino acid region of 225-232. In addition, Tax1 but not Tax2 or Tax1/225-232 interacted with p65, p50, and c-Rel; however, the interactions were much less than those noted with NF-κB2/p100/p52 and RelB. OX40L is a T-cell costimulatory molecule of the tumor necrosis factor family, and its signal plays a critical role in establishing adaptive immunity by inducing the polarized differentiation of T-cells to cells such as T helper type 2 and T follicular helper cells. Therefore, the present findings suggest that Tax1 might alter the immune response to HTLV-1 and/or differentiation of HTLV-1-infected T-cells via OX40L induction, thereby acting as a factor mediating the distinct phenotypes and pathogenesis of HTLV-1 from that of HTLV-2.

Entities:  

Keywords:  HTLV-1; NF-κB; OX40L; RelB; p52

Mesh:

Substances:

Year:  2016        PMID: 26739459     DOI: 10.1007/s11262-015-1277-7

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  47 in total

1.  The PDZ domain-binding motif of the human T cell leukemia virus type 1 tax protein induces mislocalization of the tumor suppressor hScrib in T cells.

Authors:  Charlotte Arpin-André; Jean-Michel Mesnard
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

2.  Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells.

Authors:  Michitaka Imai; Masaya Higuchi; Hiroki Kawamura; Manami Yoshita; Masahiko Takahashi; Masayasu Oie; Hideaki Matsuki; Yuetsu Tanaka; Yutaka Aoyagi; Masahiro Fujii
Journal:  Virus Genes       Date:  2012-09-29       Impact factor: 2.332

Review 3.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

4.  HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs.

Authors:  O J Semmes; F Majone; C Cantemir; L Turchetto; B Hjelle; K T Jeang
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

5.  OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.

Authors:  Clément Jacquemin; Nathalie Schmitt; Cécile Contin-Bordes; Yang Liu; Priya Narayanan; Julien Seneschal; Typhanie Maurouard; David Dougall; Emily Spence Davizon; Hélène Dumortier; Isabelle Douchet; Loïc Raffray; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Marie-Elise Truchetet; Liliane Khoryati; Patrick Mercié; Lionel Couzi; Pierre Merville; Thierry Schaeverbeke; Jean-François Viallard; Jean-Luc Pellegrin; Jean-François Moreau; Sylviane Muller; Sandy Zurawski; Robert L Coffman; Virginia Pascual; Hideki Ueno; Patrick Blanco
Journal:  Immunity       Date:  2015-06-09       Impact factor: 31.745

6.  Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.

Authors:  Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno
Journal:  Int J Cancer       Date:  1991-06-19       Impact factor: 7.396

Review 7.  OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.

Authors:  Naoto Ishii; Takeshi Takahashi; Pejman Soroosh; Kazuo Sugamura
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

8.  Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants.

Authors:  Shibani Mitra-Kaushik; John C Harding; Jay L Hess; Lee Ratner
Journal:  Blood       Date:  2004-04-15       Impact factor: 22.113

9.  Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type 1 Tax protein.

Authors:  Kojiro Ishioka; Masaya Higuchi; Masahiko Takahashi; Sakiko Yoshida; Masayasu Oie; Yuetsu Tanaka; Sugata Takahashi; Li Xie; Patrick L Green; Masahiro Fujii
Journal:  Retrovirology       Date:  2006-10-17       Impact factor: 4.602

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  8 in total

Review 1.  HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role.

Authors:  Stefania Fochi; Simona Mutascio; Umberto Bertazzoni; Donato Zipeto; Maria G Romanelli
Journal:  Front Microbiol       Date:  2018-02-21       Impact factor: 5.640

2.  Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.

Authors:  Tadasuke Naito; Jun-Ichirou Yasunaga; Yuichi Mitobe; Kazumasa Shirai; Hiroe Sejima; Hiroshi Ushirogawa; Yuetsu Tanaka; Tatsufumi Nakamura; Kousuke Hanada; Masahiro Fujii; Masao Matsuoka; Mineki Saito
Journal:  Retrovirology       Date:  2018-11-06       Impact factor: 4.602

Review 3.  Comparative virology of HTLV-1 and HTLV-2.

Authors:  Michael P Martinez; Jacob Al-Saleem; Patrick L Green
Journal:  Retrovirology       Date:  2019-08-07       Impact factor: 4.602

4.  Alternative NF-κB Signaling Discriminates Induction of the Tumor Marker Fascin by the Viral Oncoproteins Tax-1 and Tax-2 of Human T-Cell Leukemia Viruses.

Authors:  Stefanie Heym; Caroline F Mohr; Hanna C Engelbrecht; Bernhard Fleckenstein; Andrea K Thoma-Kress
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 5.  Drosophila as a Model for Infectious Diseases.

Authors:  J Michael Harnish; Nichole Link; Shinya Yamamoto
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

6.  Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.

Authors:  Meng Wang; Wei Yang; Yu Chen; Jian Wang; Juan Tan; Wentao Qiao
Journal:  Retrovirology       Date:  2018-09-21       Impact factor: 4.602

7.  The low spike density of HIV may have evolved because of the effects of T helper cell depletion on affinity maturation.

Authors:  Assaf Amitai; Arup K Chakraborty; Mehran Kardar
Journal:  PLoS Comput Biol       Date:  2018-08-30       Impact factor: 4.475

8.  Prototype foamy virus downregulates RelB expression to facilitate viral replication.

Authors:  Junshi Zhang; Chenchen Wang; Xiaopeng Tuo; Keli Chai; Yali Xu; Wentao Qiao; Juan Tan
Journal:  FEBS Open Bio       Date:  2020-09-15       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.